)
)
)
Ubix Therapeutics
Ubix Therapeutics is a clinical-stage biotechnology company focused on Targeted Protein Degradation (TPD) and Degrader-Antibody Conjugate (DAC) therapeutics, with a primary emphasis on oncology.
Address
SeoulSouth Korea
South Korea
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)